Areas of Expertise / Conditions Treated
- Head and Neck Cancer
- Lung Cancer
- Oral Cancer
- Assistant Professor of Medicine at CUMC
- NewYork-Presbyterian Lawrence Hospital
Schedule an Appointment
1199 National Benefit Fund
- 1199 National Benefit Fund
Affinity Health Plan
- Amida Care
Anthem Blue Cross Blue Shield
- Anthem Blue Cross Blue Shield
Empire Blue Cross/Blue Shield
- Empire Blue Cross Blue Shield
- Fidelis Care
MVP Health Care
- MVP Health Care
- VNSNY CHOICE
Credentials & Experience
Education & Training
- Medical Doctor (MD), New York Presbyterian Hospital
- Residency: 2005 SUNY Stony Brook University Hospital
- Fellowship: 2008 Albert Einstein College of Medicine
- Medical Oncology
Dr. Smith-Marrone is currently the Director of Cancer Clinical Trials at NYP/Lawrence Hospital and also refers lung and head and neck cancer patients to clinical trials available through Herbert Irving Comprehensive Cancer Center at Columbia University.
Susana Hernandez, Tiffany Negri, Adrian G. Sacher, Stephanie Smith-Marrone, Mark Stoopler, Justin F. Gainor, Mark M. Awad, Frank D'Ovidio, Joshua R. Sonett, Matthew Bacchetta, Anjali Saqi, Naiyer A. Rizvi; Columbia University Medical Center, New York, NY; Dana-Farber Cancer Institute, Boston, MA; Massachusetts General Hospital, Boston, MA; Massachusetts General Hospital, Cambridge, MA. "Neoadjuvant atezolizumab + chemotherapy in resectable non-small cell lung cancer (NSCLC)." J Clin Oncol 36, 2018 (suppl; abstr 8532)
M.C. Pietanza, MatthewD. Hellmann, John J. Fiore, Stephanie Smith-Marrone, Ethan M. Basch, Lawrence H. Schwartz, Michelle S. Ginsberg, Marwan Shouery, Samantha K. Newman, Mary Shaw, Lauren J. Rogak, Alex E. Lash, Patrick Hilden, Mark G. Kris, "Phase II Study of a Non-Platinum-Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas. J Thor Oncol. 2016; 11: 890-899.
Waldman, Abigail H., Jennifer M. Mcniff, Annmarie Liapakis, William S. Asch, Stephanie Smith-Marrone, and Oscar R. Colegio. Revision of Immunosuppression in a Solid Organ Transplant Recipient Leads to Complete Remission of Metastatic Undifferentiated Carcinoma." JAAD Case Reports 1.6 (2015): S8-S11.
Fury, M. G., Xiao, H., Sherman, E. J., Baxi, S., Smith-Marrone, S., Schupak, K., Gewanter, R., Gelblum, D., Haque, S., Schoder, H., Shah, J. P., Katabi, N., Kurtzman, R., Lipson, B., Cox, L., Lee, N. Y. and Pfister, D. G. (2015), Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma. Head Neck. doi: 10.1002/hed.24041
Gregory J. Riely, Helena Alexandra Yu, Dennis Stephens, Maria Catherine Pietanza, Stephanie Smith-Marrone, John Joseph Fiore, Melissa Goldstein, Camelia S. Sima, Mark G. Kris, and Michelle S. Ginsberg. A Phase I Study of Crizotinib and ganestespib (STA-9090) in ALK positive lung cancers. J Clin Oncol (Meeting Abstracts) May 2015 vol. 33 no. 15_suppl 8064.